June 4, 2020 — Amid the Covid-19 pandemic, many companies in the industry and beyond are sharing their efforts to help eyecare professionals, and the public, weather these turbulent times.
Here, we share a roundup of some recent initiatives:
Alcon has launched the “No Reason to Wait: Success Starts Now” program. “The Covid-19 crisis created a backlog of dry eye patients who might be looking for treatment of Meibomian Gland Dysfunction (MGD), the root cause of their evaporative dry eye disease,” says Adam Szaronos, Alcon’s head of U.S. dry eye devices. “This presents a unique opportunity for eyecare practitioners looking to bring more value to each patient coming through their doors. The ‘No Reason to Wait’ program brings together leading MGD technology, a proven implementation program, and a newly launched platform for driving longterm patient compliance and retention for practices offering procedures with the Systane iLux system. The program will help eye doctors deliver effective solutions to more patients, create new avenues of revenue at a time of critical need, and address barriers that might prevent successful practice entry and adoption of MGD procedures.”
L’Amy America announced it has joined Shamir’s Better Together program, available through Aug. 31, 2020. “The Better Together package will give ECPs a financially strong package for their bottom line as they begin the recovery process, and will help the patient as well, giving them the choice of our strong frame brands in conjunction with Shamir’s high-quality lenses. It’s a win-win for our ECP’s and we’re excited to be a part of it,” says Stephen Rappoport, CEO of L’Amy America.
Marcolin continues its customer support with its 360-degree training and resource initiative, launched in April. For the full calendar of webinars, updated weekly: my.marcolin.com/lp/webinars.
As a solution to help lower the risk of infection in the optical dispensary, Smart Mirror captures patients’ measurements from a safer distance. Smart Mirror technology also aids in frame choice and augmented reality simulations for lenses.